Single-specialty interventional pain management startup Nivaan Care has raised $7 million in a Series A funding round as it looks to scale its presence across India. The round was led by Sorin Investments, with participation from existing backers W Health Ventures, Endiya Partners, and Rebright Partners.
The fresh capital will be used to expand Nivaan Care’s clinic network into more Indian cities, strengthen its clinical and operational backbone, and continue developing innovative, minimally invasive treatments for chronic pain.
As India faces a growing burden of chronic pain conditions, Nivaan Care is positioning itself as a focused, specialized healthcare provider aiming to deliver effective, non-surgical pain relief at scale.
Understanding Nivaan Care’s Focus on Pain Management
A Single-Specialty Approach to a Widespread Problem
Chronic pain affects millions of people in India, yet it often remains underdiagnosed or poorly managed. Patients frequently move between orthopaedic doctors, neurologists, and surgeons without finding long-term relief.
Nivaan Care takes a different approach by operating single-specialty clinics dedicated entirely to interventional pain management. Rather than offering general healthcare services, the company focuses exclusively on diagnosing and treating chronic pain conditions.
This sharp focus allows the startup to build deep expertise, standardized protocols, and consistent patient outcomes across its clinics.
What Makes Nivaan Care’s Care Model Different
Multidisciplinary, Patient-Centered Treatment
Nivaan Care follows a multidisciplinary care model that brings together pain physicians, physiotherapists, and care coordinators under one roof. This integrated approach ensures that patients receive comprehensive care rather than fragmented treatment.
Instead of immediately recommending surgery, the clinics emphasize non-surgical and minimally invasive procedures that aim to reduce pain, improve mobility, and restore quality of life.
Focus on Minimally Invasive Procedures
The startup specializes in modern interventional pain management techniques, which often involve image-guided injections, nerve blocks, and other targeted procedures. These treatments typically require shorter recovery times, lower risk, and less disruption to daily life compared to traditional surgery.
By prioritizing such methods, Nivaan Care aims to offer patients effective alternatives before surgery becomes the only option.
How the $7 Million Funding Will Be Used
Expanding the Clinic Network
A major portion of the funding will be directed toward expanding Nivaan Care’s physical footprint. The company plans to open new clinics across multiple Indian cities, increasing access to specialized pain management services.
This expansion is expected to focus not only on major metros but also on high-potential satellite markets where access to advanced pain treatment remains limited.
Strengthening Clinical and Operating Infrastructure
As the network grows, Nivaan Care plans to invest heavily in its clinical systems, training programs, and operational processes. Standardizing care delivery across locations will be critical to maintaining quality and patient outcomes.
The company also aims to enhance its internal technology systems to support patient management, follow-ups, and outcome tracking.
Innovating in Pain Treatment Techniques
Another key focus area will be continued innovation in minimally invasive pain management procedures. Nivaan Care intends to stay at the forefront of evolving treatment methods by adopting new techniques, refining protocols, and investing in clinician training.
Current Presence and Performance
Clinics Across Key Indian Markets
Nivaan Care currently operates pain management clinics across Delhi-NCR, Mumbai, and other satellite markets such as Jaipur and Lucknow. These locations were chosen strategically to balance scale with accessibility.
The startup’s presence in both metro and non-metro markets highlights its ambition to build a nationwide network rather than remain concentrated in a few urban centers.
Strong Early Traction
Since its inception, Nivaan Care claims to have completed over 40,000 patient consultations and approximately 5,000 minimally invasive procedures. According to the company, a significant proportion of patients have reported notable pain reduction and functional improvement.
These early results have helped the startup build credibility among patients as well as investors looking for scalable healthcare models with measurable outcomes.
Why Investors Are Betting on Nivaan Care
A Large and Growing Market Opportunity
Chronic pain is a long-term health issue driven by aging populations, sedentary lifestyles, and rising rates of musculoskeletal disorders. Despite its prevalence, specialized pain management remains underpenetrated in India.
Investors see strong potential in a focused, clinic-based model that addresses this gap with standardized care and repeatable operations.
Predictable and Scalable Healthcare Model
Unlike general hospitals, single-specialty clinic chains can scale more efficiently by replicating proven processes across locations. Nivaan Care’s standardized protocols and focused service offerings make it well-suited for this model.
The company’s emphasis on minimally invasive procedures also aligns with global healthcare trends that prioritize faster recovery and lower costs.
The Bigger Picture: The Future of Pain Management in India
Moving Beyond Surgery-First Thinking
Historically, many chronic pain patients in India have been pushed toward surgery as a default option. However, advances in interventional pain medicine are changing this mindset.
Companies like Nivaan Care are helping shift the focus toward evidence-based, non-surgical interventions that can deliver meaningful relief with fewer risks.
Specialized Clinics as the Future of Care Delivery
As healthcare becomes more specialized, single-specialty clinics are emerging as a preferred model for both patients and providers. They offer focused expertise, consistent quality, and better patient experiences.
Nivaan Care’s expansion reflects this broader shift in how healthcare services are being designed and delivered.
What Lies Ahead for Nivaan Care
With fresh funding in place, Nivaan Care is entering a new phase of growth. The company’s immediate priorities include expanding its geographic reach, deepening clinical capabilities, and continuing to build trust among patients seeking long-term pain relief.
If executed well, the startup has the potential to become a leading name in India’s interventional pain management space and set new benchmarks for specialized healthcare delivery.
Final Thoughts
Nivaan Care’s $7 million Series A funding round highlights growing investor confidence in focused healthcare models that address real, unmet needs. By combining specialized clinical expertise with a scalable clinic network, the startup is tackling one of India’s most persistent health challenges.
As chronic pain continues to impact millions of lives, Nivaan Care’s approach could play a meaningful role in reshaping how pain is treated across the country.
